無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

分子イメージングの世界市場 分析と予測 (2019-2028年):装置・ソフトウェア・造影剤・用途・エンドユーザー・20ヶ国のデータ・競合情勢

Global Molecular Imaging Market: Focus on Equipment, Software, Imaging Agents, Applications, End Users, 20 Countries' Data and Competitive Landscape - Analysis and Forecast, 2019-2028

発行 BIS Research Inc. 商品コード 906895
出版日 ページ情報 英文 263 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。
Back to Top
分子イメージングの世界市場 分析と予測 (2019-2028年):装置・ソフトウェア・造影剤・用途・エンドユーザー・20ヶ国のデータ・競合情勢 Global Molecular Imaging Market: Focus on Equipment, Software, Imaging Agents, Applications, End Users, 20 Countries' Data and Competitive Landscape - Analysis and Forecast, 2019-2028
出版日: 2019年08月06日 ページ情報: 英文 263 Pages
概要

世界の分子イメージング市場規模は、2028年までに111億3,000万米ドルへ達すると予測されています。

当レポートでは、世界の分子イメージング市場について調査し、市場の概要、市場ダイナミクス、セグメント別 (製品・用途・エンドユーザー・地域) の分析と予測、および主要企業のプロファイルなど、体系的な情報を提供しています。

エグゼクティブサマリー

第1章 市場概要

第2章 市場ダイナミクス

  • 概要
  • 影響分析
  • 市場成長促進要因
  • 市場成長抑制要因
  • 市場機会

第3章 競合情勢

  • 主な発展・戦略
  • 市場シェア分析

第4章 産業考察

  • 法的要件・規制
  • 医師の認識

第5章 世界の分子イメージング市場:製品別

  • 概要
  • イメージングシステム
  • 造影剤
  • イメージングソフトウェア

第6章 世界の分子イメージング市場:用途別

  • 概要
  • 臨床用途
  • 前臨床研究

第7章 世界の分子イメージング市場:エンドユーザー別

  • 概要
  • 病院
  • 専門クリニック
  • ASC (通院外科診療所)
  • その他

第8章 世界の分子イメージング市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

  • Advanced Accelerator Applications
  • Bruker Corporation
  • キャノン
  • Cardinal Health
  • Eurocolumbus s.r.l.
  • DDD-Diagnostic A/S
  • Digirad Corporation
  • ESAOTE SPA
  • General Electric Company
  • 日立
  • Koninklijke Philips N.V.
  • PerkinElmer Inc.
  • Positron Corporation
  • Siemens Healthineers AG
  • SurgicEye GmbH
  • Thermo Fisher Scientific

第10章 調査範囲・手法

図表

List of Tables

  • Table 2.1: Market Drivers
  • Table: 2.2: Market Restraints
  • Table 2.3: Currently Used Reporter Genes
  • Table 4.1: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment, and Region
  • Table 5.1: FDA Approved Antibody-Based Imaging Agents
  • Table 8.1: Molecular imaging societies in Rest-of-Europe

List of Figures

  • Figure 1: Evolution of Molecular Imaging
  • Figure 2: Impact Analysis of Market Drivers and Market Restraints, 2018-2028
  • Figure 3: Share of Key Developments and Strategies, January 2015-July 2019
  • Figure 4: Leading Players in the Global Molecular Imaging Market
  • Figure 5: Global Molecular Imaging Market, 2018-2028
  • Figure 6: Global Molecular Imaging Market Share (By Product), 2018 and 2024
  • Figure 7: Global Molecular Imaging Market Share (By Imaging System), 2018 and 2024
  • Figure 8: Global Molecular Imaging Market Share (By Imaging Agent), 2018 and 2024
  • Figure 9: Global Molecular Imaging Market Share (By Clinical Application), 2018 and 2024
  • Figure 10: Global Molecular Imaging Market Regional Snapshot
  • Figure 1.1: Types of Molecular Imaging Technologies
  • Figure 1.2: Evolution of Molecular Imaging
  • Figure 1.3: Global Molecular Imaging Market, 2018-2028
  • Figure 3.1: Share of Key Developments and Strategies, January 2015-July 2019
  • Figure 3.2: Share of Joint Ventures, Collaborations, and Partnerships, January 2015-July 2019
  • Figure 3.3: Share of Mergers and Acquisitions, January 2015-July 2019
  • Figure 3.4: Share of Product Launches and Enhancements, January 2015-July 2019
  • Figure 3.5: Share of Awards, Recognitions, and Others, January 2015-July 2019
  • Figure 3.6: Share of Product Approvals, January 2015-July 2019
  • Figure 3.7: Share of Business Expansion Activities, January 2015-July 2019
  • Figure 3.8: Market Share Analysis: Global Molecular Imaging Market, 2018
  • Figure 3.9: Market Share Analysis: Global Molecular Imaging Market, 2017
  • Figure 3.10: Market Share Analysis: Global Molecular Imaging Market (by Systems), 2018
  • Figure 3.11: Market Share Analysis: Global Molecular Imaging Market (by Systems), 2017
  • Figure 3.12: Market Share Analysis: Global Molecular Imaging Market (by Imaging Agents), 2018
  • Figure 3.13: Market Share Analysis: Global Molecular Imaging Market (by Imaging Agents), 2017
  • Figure 3.14: Market Share Analysis: Global Molecular Imaging Market (by Imaging Software), 2018
  • Figure 3.15: Market Share Analysis: Global Molecular Imaging Market (by Imaging Software), 2017
  • Figure 5.1: Global Molecular Imaging Market (by Product), 2018-2028
  • Figure 5.2: Type of Molecular Imaging Systems
  • Figure 5.3: Global Molecular Imaging Market (by Imaging Systems), 2018-2028
  • Figure 5.4: Global Molecular Imaging Market (by Imaging Systems), 2018-2028
  • Figure 5.5: Global Molecular Imaging Market (by Multimodality Imaging), 2018-2028
  • Figure 5.6: Types of Multimodality Imaging Systems
  • Figure 5.7: Global Molecular Imaging Market (by Radionuclide Imaging), 2018-2028
  • Figure 5.8: Types of Radionuclide Imaging Systems
  • Figure 5.9: Global Molecular Imaging Market (by MRS), 2018-2028
  • Figure 5.10: Global Molecular Imaging Market (by Ultrasound Molecular Imaging), 2018-2028
  • Figure 5.11: Global Molecular Imaging Market (by Optical Imaging), 2018-2028
  • Figure 5.12: Types of Optical Imaging Systems
  • Figure 5.13: Type of Molecular Imaging Agents
  • Figure 5.14: Global Molecular Imaging Market (by Imaging Systems), 2018-2028
  • Figure 5.15: Global Molecular Imaging Market (by Imaging Agents), 2018-2028
  • Figure 5.16: Global Molecular Imaging Market (by Small Molecules), 2018-2028
  • Figure 5.17: Global Molecular Imaging Market (by Peptides), 2018-2028
  • Figure 5.18: Global Molecular Imaging Market (by Antibodies), 2018-2028
  • Figure 5.19: Global Molecular Imaging Market (by Aptamers), 2018-2028
  • Figure 5.20: Global Molecular Imaging Market (by Imaging Software), 2018-2028
  • Figure 6.1: Global Molecular Imaging Market (by Application), 2018-2028
  • Figure 6.2: Global Molecular Imaging Market (by Clinical Applications), 2018-2028
  • Figure 6.3: Global Molecular Imaging Market (by Clinical Applications), 2018-2028
  • Figure 6.4: Global Molecular Imaging Market (by Oncology), 2018-2028
  • Figure 6.5: Global Molecular Imaging Market (by Cardiology), 2018-2028
  • Figure 6.6: Global Molecular Imaging Market (by Neurology), 2018-2028
  • Figure 6.7: Global Molecular Imaging Market (by Gastroenterology), 2018-2028
  • Figure 6.8: Global Molecular Imaging Market (by Other Applications), 2018-2028
  • Figure 6.9: Global Molecular Imaging Market (by Preclinical Research), 2018-2028
  • Figure 7.1: Global Molecular Imaging Market (by End User), 2018-2028
  • Figure 7.2: Global Molecular Imaging Market (by Hospitals), 2018-2028
  • Figure 7.3: Global Molecular Imaging Market (by Specialty Clinics), 2018-2028
  • Figure 7.4: Global Molecular Imaging Market (Ambulatory Surgical Centers), 2018-2028
  • Figure 7.5: Global Molecular Imaging Market (by Others), 2018-2028
  • Figure 8.1: Global Molecular Imaging Market Scenario, 2018 and 2028
  • Figure 8.2: North America: Molecular Imaging Market, 2018-2028
  • Figure 8.3: North America: Market Dynamics
  • Figure 8.4: North America: Molecular Imaging Market (by Country), 2018 and 2028
  • Figure 8.5: The U.S.: Molecular Imaging Market, 2018-2028
  • Figure 8.6: Canada: Molecular Imaging Market, 2018-2028
  • Figure 8.7: Europe: Molecular Imaging Market, 2018-2028
  • Figure 8.8: Europe: Market Dynamics
  • Figure 8.9: Europe: Molecular Imaging Market (by Country), 2018 and 2028
  • Figure 8.10: Germany: Molecular Imaging Market, 2018-2028
  • Figure 8.11: The U.K.: Molecular Imaging Market, 2018-2028
  • Figure 8.12: France: Molecular Imaging Market, 2018-2028
  • Figure 8.13: Italy: Molecular Imaging Market, 2018-2028
  • Figure 8.14: Spain: Molecular Imaging Market, 2018-2028
  • Figure 8.15: The Netherlands: Molecular Imaging Market, 2018-2028
  • Figure 8.16: Switzerland: Molecular Imaging Market, 2018-2028
  • Figure 8.17: Rest-of-Europe: Molecular Imaging Market, 2018-2028
  • Figure 8.18: Asia-Pacific: Molecular Imaging Market, 2018-2028
  • Figure 8.19: Asia-Pacific: Market Dynamics
  • Figure 8.20: Asia-Pacific: Molecular Imaging Market, 2018-2028
  • Figure 8.21: China: Molecular Imaging Market, 2018-2028
  • Figure 8.22: Japan: Molecular Imaging Market, 2018-2028
  • Figure 8.23: India: Molecular Imaging Market, 2018-2028
  • Figure 8.24: Australia: Molecular Imaging Market, 2018-2028
  • Figure 8.25: South Korea: Molecular Imaging Market, 2018-2028
  • Figure 8.26: Rest-of-Asia-Pacific: Molecular Imaging Market, 2018-2028
  • Figure 8.27: Latin America: Molecular Imaging Market, 2018-2028
  • Figure 8.28: Latin America: Market Dynamics
  • Figure 8.29: Latin America: Molecular Imaging Market, 2018-2028
  • Figure 8.30: Brazil: Molecular Imaging Market, 2018-2028
  • Figure 8.31: Mexico: Molecular Imaging Market, 2018-2028
  • Figure 8.32: Argentina: Molecular Imaging Market, 2018-2028
  • Figure 8.33: Rest-of-Latin America: Molecular Imaging Market, 2018-2028
  • Figure 8.34: Middle East and Africa: Molecular Imaging Market, 2018-2028
  • Figure 8.35: Middle East and Africa: Market Dynamics
  • Figure 8.36: Middle East and Africa: Molecular Imaging Market, 2018-2028
  • Figure 8.37: Saudi Arabia: Molecular Imaging Market, 2018-2028
  • Figure 8.38: Israel: Molecular Imaging Market, 2018-2028
  • Figure 8.39: U.A.E: Molecular Imaging Market, 2018-2028
  • Figure 8.40: Rest-of-Middle East and Africa: Molecular Imaging Market, 2018-2028
  • Figure 9.1: Shares of Key Company Profiles
  • Figure 9.2: Advanced Accelerator Applications: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.3: Bruker Corporation: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.4: Bruker Corporation: Overall Financials, 2016-2018
  • Figure 9.5: Bruker Corporation Net Revenue (by Business Segment), 2016-2018
  • Figure 9.6: Bruker Corporation Net Revenue (by Business Sub-Segment), 2016-2018
  • Figure 9.7: Bruker Corporation: Net Revenue (by Region), 2016-2018
  • Figure 9.8: Bruker Corporation: R&D Expense, 2016-2018
  • Figure 9.9: Canon Inc.: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.10: Canon Inc.: Overall Financials, 2016-2018
  • Figure 9.11: Canon Inc. Net Revenue (by Business Segment), 2016-2018
  • Figure 9.12: Canon Inc.: Net Revenue (by Region), 2016-2018
  • Figure 9.13: Canon Inc.: R&D Expense, 2016-2018
  • Figure 9.14: Cardinal Health: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.15: Cardinal Health: Overall Financials, 2016-2018
  • Figure 9.16: Cardinal Health Net Revenue (by Business Segment), 2016-2018
  • Figure 9.17: Cardinal Health: Net Revenue (by Region), 2016-2018
  • Figure 9.18: DDD-Diagnostic A/S: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.19: Digirad Corporation: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.20: Digirad Corporation: Overall Financials, 2016-2018
  • Figure 9.21: Digirad Corporation Net Revenue (by Business Segment), 2016-2018
  • Figure 9.22: Digirad Corporation: Net Revenue (by Region), 2016-2018
  • Figure 9.23: ESAOTE SPA: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.24: General Electric Company: Product Offerings for Global Molecular Imaging Market
  • Figure 9.25: General Electric Company: Overall Financials, 2016-2018
  • Figure 9.26: General Electric Company Net Revenue (by Business Segment), 2016-2018
  • Figure 9.27: General Electric Company: Net Revenue (by Region), 2016-2018
  • Figure 9.28: General Electric Company: R&D Expense, 2016-2018
  • Figure 9.29: Hitachi, Ltd.: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.30: Hitachi, Ltd.: Overall Financials, 2016-2018
  • Figure 9.31: Hitachi, Ltd. Net Revenue (by Business Segment), 2016-2018
  • Figure 9.32: Hitachi, Ltd.: Net Revenue (by Region), 2016-2018
  • Figure 9.33: Hitachi, Ltd.: R&D Expense, 2016-2018
  • Figure 9.34: Koninklijke Philips N.V.: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.35: Koninklijke Philips N.V.: Overall Financials, 2016-2018
  • Figure 9.36: Koninklijke Philips N.V. Net Revenue (by Business Segment), 2016-2018
  • Figure 9.37: Koninklijke Philips N.V.: Net Revenue (by Region), 2016-2018
  • Figure 9.38: Koninklijke Philips N.V.: R&D Expense, 2016-2018
  • Figure 9.39: PerkinElmer Inc.: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.40: PerkinElmer Inc.: Overall Financials, 2016-2018
  • Figure 9.41: PerkinElmer Inc. Net Revenue (by Business Segment), 2016-2018
  • Figure 9.42: PerkinElmer Inc.: Net Revenue (by Region), 2016-2018
  • Figure 9.43: PerkinElmer Inc.: R&D Expense, 2016-2018
  • Figure 9.44: Positron Corporation: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.45: Siemens Healthineers AG: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.46: Siemens Healthineers AG: Overall Financials, 2016-2018
  • Figure 9.47: Siemens Healthineers AG Net Revenue (by Business Segment), 2016-2018
  • Figure 9.48: Siemens Healthineers AG: Net Revenue (by Region), 2016-2018
  • Figure 9.49: Siemens Healthineers AG: R&D Expense, 2016-2018
  • Figure 9.50: SurgicEye GmbH: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.51: Thermo Fisher Scientific: Product Offerings for the Global Molecular Imaging Market
  • Figure 9.52: Thermo Fisher Scientific: Overall Financials, 2016-2018
  • Figure 9.53: Thermo Fisher Scientific Net Revenue (by Business Segment), 2016-2018
  • Figure 9.54: Thermo Fisher Scientific: Net Revenue (by Region), 2016-2018
  • Figure 9.55: Thermo Fisher Scientific: R&D Expense, 2016-2018
  • Figure 10.1 Global Molecular Imaging Market Segmentation
  • Figure 10.2: Research Methodology
  • Figure 10.3: Primary Research
  • Figure 10.4: Secondary Research
  • Figure 10.5: Data Triangulation
  • Figure 10.6: Bottom-up Approach (Segment-wise Analysis)
  • Figure 10.7: Top-Down Approach (Segment-wise Analysis)
  • Figure 10.8: Assumptions and Limitations
  • Figure 10.9: Considered Factors for Data Prediction and Modeling
目次
Product Code: BH151A

Global Molecular Imaging Market to Reach $11.13 Billion by 2028, Reports BIS Research

Key Questions Answered in this Report:

  • What is the total market size at present and forecast for global molecular imaging market by 2028?
  • What are the current key trends witnessed by the global molecular imaging market?
  • What are the key market dynamics i.e. drivers, restraints, and opportunities for molecular imaging market?
  • How would artificial intelligence-enabled image analytics result in a dynamic shift in the growth of molecular imaging market during the forecast period?
  • What are the key strategies incorporated by the leading players of molecular imaging market?
  • What is the market share of key competitors for the product categories?
  • What are the regulations influencing molecular imaging market, across regions?
  • What is the current total market size and the forecast for different product categories available in molecular imaging market by 2028?
  • How would imaging agents evolve to be dominating contributors in the global molecular imaging market revenue and why?
  • What is the current total market estimation and forecasts of molecular imaging products across different countries by 2028?

Global Molecular Imaging Market Value and Estimation

As per the global molecular imaging market analysis conducted by BIS Research, the market was valued at approximately $6.84 billion in 2018 and is anticipated to reach $11.13 billion by 2028. Presently, the incidence of chronic disorders such as cardiovascular, oncological, and neurological disorders is rising at alarming rates and is creating an increased economic burden on the healthcare providers and the patients.

To combat the growing incidence and to reduce the costs associated with disease management healthcare providers as well as the researchers are promoting and identifying novel methods for preventive care and early detection. Molecular imaging is one such highly advanced method in the field of medical imaging which allows the functional diagnosis and aids in the characterization of the physiological events at the cellular and molecular level.

Expert Quote on Global Molecular Imaging Market

"North America is currently the leading contributor to the molecular imaging market. The market was valued $3.89 billion in 2018. Factors such as rising demand for minimally invasive surgeries, increasing cases of chronic diseases, approval of novel radiotracers, and the growing awareness regarding molecular imaging are driving the growth of the North American molecular imaging market. However, the Asia-Pacific is expected to register the highest CAGR of 6.68% during the forecast period 2019-2028".

Scope of the Market Intelligence on Global Molecular Imaging Market

The purpose of the study is to gain a holistic view of the molecular imaging market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products allied with the molecular imaging market, which include imaging systems, imaging agents, and imaging software.

The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

Market Segmentation

The global molecular imaging market is segmented into four different parts: by product, by application, by end user, and by region. The global market value was estimated using these three different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation.

With the increasing incidence of chronic disorders, increased digital platform penetration, and the increased utilization of molecular imaging in disciplines such as precision medicine the molecular imaging market is expected to witness a gradual growth. Moreover, the ongoing technological advancements have led to the identification of multimodality molecular imaging technology as an innovative approach for the functional as well as anatomical diagnosis.

The use of multimodality imaging techniques including PET-MRI, PET-CT, and SPECT-CT is becoming increasingly prevalent attributed to which the multimodality imaging technology is expected to dominate the market. Moreover, with the advent of novel imaging agents including the multimodality reporter genes is expected to expand the clinical application of techniques such as optical imaging and targeted molecular ultrasound because of which these segments are expected to witness an impressive CAGR during the forecast period.

The global molecular imaging market is segmented by the geographical regions into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is the leading contributor to the global molecular imaging market followed by Europe. However, the Asia-Pacific region is expected to register a highest CAGR during the forecast period.

The global molecular imaging market is dominated by the U.S. and the European players. The U.S.-based companies, Cardinal Health and General Electric Company and the European companies Siemens Healthcare GmbH and Koninklijke Philips N.V. GmbH accounted for more than 70% of the market value in 2018.

Key Players in the Market

The key players who have significant contributions to the global molecular imaging equipment market are Advanced Accelerator Applications, Bruker Corporation, Canon Inc., Digirad Corporation, ESAOTE SPA, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V. GmbH, PerkinElmer Inc., Positron Corporation, Siemens Healthcare GmbH, SurgicEye GmbH, and Thermo Fisher Scientific, among others.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Advent and Evolution of Molecular Imaging
    • 1.1.1 Advantages of Molecular Imaging
  • 1.2 Emerging Trends in Medical Imaging and Impact on Molecular Imaging Market
  • 1.3 Awaited Technological Advancements
  • 1.4 Global Molecular Imaging Market Scenario
    • 1.4.1 Global Molecular Imaging Addressable Market and Future Potential (2018-2029)
    • 1.4.2 Assumptions and Limitations

2 Market Dynamics

  • 2.1 Overview
  • 2.2 Impact Analysis
  • 2.3 Market Drivers
    • 2.3.1 Rising Incidence of Disorders Inciting the use of Molecular Imaging
    • 2.3.2 Utilization of Molecular Imaging to Inform Advances in Precision Medicine
    • 2.3.3 Increased Penetration of Digital Platforms
  • 2.4 Market Restraints
    • 2.4.1 Lack of Specificity for the Diagnosis of Infectious Diseases
    • 2.4.2 Stringent Regulatory Requirements
    • 2.4.3 Poor Reimbursement Scenario
  • 2.5 Market Opportunities
    • 2.5.1 Advent of Multimodality Reporter Genes
    • 2.5.2 Rise in Strategic Collaborations
    • 2.5.3 Significant Technological Advancements in Cardiac Imaging and Oncology

3 Competitive Landscape

  • 3.1 Key Strategies and Developments (2016-2019)
    • 3.1.1 Joint Ventures, Collaborations, and Partnerships
    • 3.1.2 Mergers and Acquisitions
    • 3.1.3 Product Launches and Enhancements
    • 3.1.4 Awards, Recognitions, and Others
    • 3.1.5 Product Approvals
    • 3.1.6 Business Expansion Activities
  • 3.2 Market Share Analysis
    • 3.2.1 Global Molecular Imaging Systems Market Share Analysis
    • 3.2.2 Global Molecular Imaging Agents Market Share Analysis
    • 3.2.3 Global Molecular Imaging Software Market Share Analysis

4 Industry Insights

  • 4.1 Legal Requirements and Regulations
    • 4.1.1 Regulations in the U.S.
    • 4.1.2 Regulations in Europe
    • 4.1.3 Regulations in Other Countries
    • 4.1.4 Consortiums, Associations, and Regulatory Bodies
  • 4.2 Physicians' Perception

5 Global Molecular Imaging Market (by Product)

  • 5.1 Overview
  • 5.2 Imaging Systems
    • 5.2.1 Multimodality Imaging
    • 5.2.2 Radionuclide Imaging
      • 5.2.2.1 Positron Emission Tomography (PET)
      • 5.2.2.2 Single Photon Emission Computed Tomography (SPECT)
    • 5.2.3 Magnetic Resonance Spectroscopy (MRS)
    • 5.2.4 Ultrasound Molecular Imaging
    • 5.2.5 Optical Imaging
      • 5.2.5.1 Fluorescence Imaging
      • 5.2.5.2 Bioluminescence Imaging (BLI)
  • 5.3 Imaging Agents
    • 5.3.1 Small Molecules
    • 5.3.2 Peptides
    • 5.3.3 Antibodies
    • 5.3.4 Aptamers
  • 5.4 Imaging Software

6 Global Molecular Imaging Market (by Application)

  • 6.1 Overview
  • 6.2 Clinical Applications
    • 6.2.1 Oncology
    • 6.2.2 Cardiology
    • 6.2.3 Neurology
    • 6.2.4 Gastroenterology
    • 6.2.5 Other Applications
  • 6.3 Preclinical Research

7 Global Molecular Imaging Market (by End User)

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Specialty Clinics
  • 7.4 Ambulatory Surgical Centers
  • 7.5 Others

8 Global Molecular Imaging Market (by Region)

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
    • 8.3.7 Switzerland
    • 8.3.8 Rest-of-Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest-of-Asia-Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest-of-Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 Israel
    • 8.6.3 U.A.E
    • 8.6.4 Rest-of-Middle East and Africa

9 Company profile

  • 9.1 Advanced Accelerator Applications
    • 9.1.1 Company Overview
    • 9.1.2 Role of Advanced Accelerator Applications in the Global Molecular Imaging Market
    • 9.1.3 SWOT Analysis: Advanced Accelerator Applications
  • 9.2 Bruker Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Role of Bruker Corporation in the Global Molecular Imaging Market
    • 9.2.3 Financials
      • 9.2.3.1 Key Insights on the Financial Health of the Company
    • 9.2.4 SWOT Analysis: Bruker Corporation
  • 9.3 Canon Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Role of Canon Inc. in the Global Molecular Imaging Market
    • 9.3.3 Financials
      • 9.3.3.1 Key Insights on the Financial Health of the Company
    • 9.3.4 SWOT Analysis: Canon Inc.
  • 9.4 Cardinal Health
    • 9.4.1 Company Overview
    • 9.4.2 Role of Cardinal Health in the Global Molecular Imaging Market
    • 9.4.3 Financials
    • 9.4.4 SWOT Analysis: Cardinal Health
  • 9.5 DDD-Diagnostic A/S
    • 9.5.1 Company Overview
    • 9.5.2 Role of DDD-Diagnostic A/S in the Global Molecular Imaging Market
    • 9.5.3 SWOT Analysis: DDD-Diagnostic A/S
  • 9.6 Digirad Corporation
    • 9.6.1 Company Overview
    • 9.6.2 Role of Digirad Corporation in the Global Molecular Imaging Market
    • 9.6.3 Financials
      • 9.6.3.1 Key Insights on the Financial Health of the Company
    • 9.6.4 SWOT Analysis: Digirad Corporation
  • 9.7 ESAOTE SPA
    • 9.7.1 Company Overview
    • 9.7.2 Role of ESAOTE SPA in the Global Molecular Imaging Market
    • 9.7.3 SWOT Analysis: ESAOTE SPA
  • 9.8 General Electric Company
    • 9.8.1 Company Overview
    • 9.8.2 Role of General Electric Company in the Global Molecular Imaging Market
    • 9.8.3 Financials
      • 9.8.3.1 Key Insights on the Financial Health of the Company
    • 9.8.4 SWOT Analysis: General Electric Company
  • 9.9 Hitachi, Ltd.
    • 9.9.1 Company Overview
    • 9.9.2 Role of Hitachi, Ltd. In the Global Molecular Imaging Market
    • 9.9.3 Financials
      • 9.9.3.1 Key Insights on the Financial Health of the Company
    • 9.9.4 SWOT Analysis: Hitachi, Ltd.
  • 9.10 Koninklijke Philips N.V.
    • 9.10.1 Company Overview
    • 9.10.2 Role of Koninklijke Philips N.V. In the Global Molecular Imaging Market
    • 9.10.3 Financials
      • 9.10.3.1 Key Insights on the Financial Health of the Company
    • 9.10.4 SWOT Analysis: Koninklijke Philips N.V.
  • 9.11 PerkinElmer Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Role of PerkinElmer Inc. in the Global Molecular Imaging Market
    • 9.11.3 Financials
      • 9.11.3.1 Key Insights on the Financial Health of the Company
    • 9.11.4 SWOT Analysis: PerkinElmer Inc.
  • 9.12 Positron Corporation
    • 9.12.1 Company Overview
    • 9.12.2 Role of Positron Corporation in the Global Molecular Imaging Market
    • 9.12.3 SWOT Analysis: Positron Corporation
  • 9.13 Siemens Healthineers AG
    • 9.13.1 Company Overview
    • 9.13.2 Role of Siemens Healthineers AG in the Global Molecular Imaging Market
    • 9.13.3 Financials
      • 9.13.3.1 Key Insights on the Financial Health of the Company
    • 9.13.4 SWOT Analysis: Siemens Healthineers AG
  • 9.14 SurgicEye GmbH
    • 9.14.1 Company Overview
    • 9.14.2 Role of SurgicEye GmbH in the Global Molecular Imaging Market
    • 9.14.3 SWOT Analysis: SurgicEye GmbH
  • 9.15 Thermo Fisher Scientific
    • 9.15.1 Company Overview
    • 9.15.2 Role of Thermo Fisher Scientific in the Global Molecular Imaging Market
    • 9.15.3 Financials
      • 9.15.3.1 Key Insights on the Financial Health of the Company
    • 9.15.4 SWOT Analysis: Thermo Fisher Scientific

10 Research Scope and Methodology

  • 10.1 Product Definition
  • 10.2 Scope of Research Study
  • 10.3 Global Molecular Imaging Market: Research Methodology
Back to Top